Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells

Daunorubicin is an anticancer drug, and cholesterol is involved in cancer progression, but their relationship has not been defined. In this study, we developed a novel experimental model that utilizes daunorubicin, cholesterol, and daunorubicin plus cholesterol in the same cells (H35) to search for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Codini, Michela, Conte, Carmela, Cataldi, Samuela, Arcuri, Cataldo, Lazzarini, Andrea, Ceccarini, Maria Rachele, Patria, Federica, Floridi, Alessandro, Mecca, Carmen, Ambesi-Impiombato, Francesco Saverio, Beccari, Tommaso, Curcio, Francesco, Albi, Elisabetta
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6274808/
https://ncbi.nlm.nih.gov/pubmed/30388783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113424
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados